Local residents enter Susan G. Komen honor roll
Among the 104 inductees into this year’s Susan G. Komen’s Pink Honor Roll are two women in the northeast Houston area — Karen Rayford of Atascocita and Carrie Brinsden of Kingwood — according to an April 18 press release from the breast cancer organization.
At the annual dinner event held April 16 at The Houstonian Hotel and Conference Center, individuals who raised $1,000 or more to fund researches relating to combating breast cancer were inducted into the Pink Honor Roll. Rayford garnered $1,285 and Brinsden got $1,150.
“I am a two-time breast cancer survivor, and giving back to Susan G. Komen gives me an opportunity to do more for the organization who has done so much for me,” said Rayford. “And, I love the people!”
Rayford, according to the press release, previously supported the 2018 Race for the Cure, an annual signature event from Komen Houston where participants enter 5K runs or fitness walks to raise funds and awareness.
Brinsden used to be a board member for Komen Houston. She raised the funds in honor of her sister, Mary Short, who was diagnosed with breast cancer in 2007 and after 12 years living with it died at 49 years old, according to the press release.
“I do this to give back in honor of her, so someone else doesn’t have to lose someone they love to breast cancer, too,” she said.
Also celebrated at the dinner were teams who raised at least $10,000. They got to enter the Pink Power League.
“We are investing more than $1 million in the community through research, grants and direct services,” said Julie Voss, executive director of Komen Houston. “Komen Houston is definitely so much more than ‘pink.’ Komen is where the end of breast cancer begins.”
The 2019 Race for The Cure is set for October 5. Participants can register and find additional information at komen-houston.org.
Last year’s run, or the 28th iteration of the event, saw more than 15,000 in attendance.
Susan G. Komen was founded in 1982 by Nancy Brinker in Dallas. The nonprofit, throughout its existence, has supported the research, advocacy and education of breast cancer in the U.S.